Prinsip dan Aplikasi Hewan Model dalam Penelitian Kanker

Penulis

Prof. Dr. Drs. H. Kusmardi, M.Sc., CIRR
Universitas Indonesia
Prof. drh. Bambang Pontjo Priosoeryanto, M.S., Ph.D., APVet., DACCM
Institut Pertanian Bogor image/svg+xml
Dr. drh. Rahayu Woro Wiranti
Institut Pertanian Bogor image/svg+xml

Kata Kunci:

Prinsip, Aplikasi Hewan Model, Penelitian Kanker

Sinopsis

Pengembangan terapi antikanker yang efektif dan aman merupakan salah satu tantangan terbesar dalam dunia medis modern. Kemajuan fundamental dalam bidang ini sangat bergantung pada penggunaan model praklinis yang mampu mereplikasi kompleksitas biologi tumor manusia secara akurat. Buku ajar ini disusun untuk mengisi celah penting dalam literatur ilmiah berbahasa Indonesia, dengan menyajikan panduan komprehensif mengenai penggunaan hewan model non-rekayasa genetika (Non-GMO) dalam penelitian onkologi. Fokus utama buku ini adalah pada model-model yang diinduksi secara kimiawi atau melalui transplantasi, yang sering kali menawarkan keunggulan dalam meniru heterogenitas dan progresi sporadis kanker pada manusia. Urgensi pemahaman mendalam terhadap model-model ini semakin meningkat seiring dengan kesadaran akan pentingnya validitas eksternal dan relevansi klinis dari sebuah penelitian. Tujuan penulisan buku ini adalah untuk membekali para mahasiswa, peneliti, dan akademisi dengan pengetahuan teoretis dan praktis yang kokoh, mulai dari filosofi pemilihan model, standardisasi prosedur, hingga analisis hasil yang valid dan etis.

Bab

  • PRAKATA
  • KATA PENGANTAR
  • DAFTAR ISI
  • Bab 1 FILOSOFI DAN JUSTIFIKASI PENGGUNAAN HEWAN MODEL
  • Bab 2 STANDAR LINGKUNGAN DAN NUTRISI UNTUK HEWAN MODEL KANKER
  • Bab 3 UJI TOKSISITAS BAHAN ALAM UNTUK RISET ANTIKANKER
  • Bab 4 RUTE PEMBERIAN KANDIDAT OBAT ANTIKANKER
  • Bab 5 MONITORING TUMOR
  • Bab 6 PROSEDUR NEKROPSI DAN PENGAMBILAN SAMPEL BIOLOGIS
  • Bab 7 MODEL KANKER PAYUDARA
  • Bab 8 MODEL KANKER KOLOREKTAL
  • Bab 9 MODEL KANKER KULIT
  • Bab 10 MODEL KANKER PROSTAT
  • Bab 11 MODEL KANKER DARAH DAN KELENJAR GETAH BENING (LEUKEMIA & LYMPHOMA)
  • Bab 12 ANALISIS EFEK ANTIKANKER PADA HEWAN MODEL KANKER
  • Bab 13 PEMBACAAN SEDIAAN IMUNOHISTOKIMIA MENGGUNAKAN SOFTWARE
  • Bab 14 ETIKA PENELITIAN DAN PENYUSUNAN DOKUMEN KAJI ETIK (ETHICAL CLEARANCE)
  • REFERENSI
  • GLOSARIUM
  • PROFIL PENULIS

Unduhan

Data unduhan belum tersedia.

Biografi Penulis

Prof. Dr. Drs. H. Kusmardi, M.Sc., CIRR, Universitas Indonesia

Prof. Dr. Drs. H. Kusmardi, M.Sc., CIRR adalah Guru Besar Tetap di Fakultas Kedokteran, Universitas Indonesia. Sekarang adalah mahasiswa Program Studi Doktor Ilmu Dakwah di Fakultas Ilmu Agama Islam, Universitas Islam Asy-Syafi’iyah Jakarta. Pendidikan Doktor sebelumnya ditempuh di Program Doktor Ilmu Biomedik FKUI Jakarta dan Program Doktor Ilmu Biomedis Hewan IPB Bogor. Program Magister di FKUI, Program S1 di Biologi FMIPA UI. Pernah Belajar Biologi Molekular di Melborne University. SD sampai SMA di kota kelahirannya, Sumenep, Madura. Bidang penelitian utamanya meliputi kanker kolorektal dan kanker payudara, dengan penekanan khusus pada eksplorasi potensi efek penghambatan berbagai obat alami Indonesia terhadap karsinogenesis pada kedua jenis kanker tersebut. Penelitiannya juga melibatkan identifikasi jaringan normal versus perkembangan kanker menggunakan penanda molekuler dan model komputasional. Selain itu, ia telah menulis beberapa buku, diantaranya: The Mouse Model for Breast Cancer; The Mouse Model for Colorectal Cancer; Lunasin: A Soybean Polypeptide as a Chemopreventive Adjuvant for Colon Cancer; Pembuatan Antibodi Poliklonal, Peristiwa Ilmiah yang telah Dijelaskan dalam Al-Qur’an, Manusia dan Semesta yang telah Dijelaskan dalam Al-Qur’an, Pemilihan Uji Statistik Kedokteran, Desain Penelitian Kedokteran dan Kesehatan, Pulasan Imunoflouresensi dan Aplikasinya, dan Filsafat untuk Calon Doktor Rumpun Ilmu Kesehatan. Selama ini beliau sudah menghasilkan seratus lebih publikasi internasional bereputasi terindeks Scopus, puluhan hak kekayaan intelektual. Saat ini Prof. Kusmardi menjadi dosen home base di Program Studi Doktor Ilmu Biomedik FKUI, selain dosen tetap di Prodi Magister Ilmu Biomedik, Prodi Dokter Spesialis Patologi Anatomik, dan Prodi Pendidikan Dokter FKUI. Beliau secara aktif menjadi Reviewer internal hibah UI dan Reviewer Nasional Proposal Hibah Kemendiktisaintek, Auditor Internal Akademik UI, PIC QA Drug Development Research Center IMERI FKUI, Cancer drug discovery coordinator di Human Cancer Research Center IMERI FKUI, tim penjamin mutu akademik Program Doktor Ilmu Kedokteran FKUI, serta sebagai Asesor LAM-PTKes divisi Kedokteran. Untuk mempertajam khasanah pengetahuannya, beliau juga menjadi Ketua Dewan Redaksi Majalah Patologi Indonesia, serta aktif menjadi reviewer tetap pada beberapa jurnal internasional terindeks scopus Q1. Kemampuan mengenalkan statistik diperoleh sejak mengajar statistic di prodi S1, Spesialis, dan S3 sejak lama.

Prof. drh. Bambang Pontjo Priosoeryanto, M.S., Ph.D., APVet., DACCM, Institut Pertanian Bogor

Prof. drh. Bambang Pontjo Priosoeryanto, M.S., Ph.D., APVet., DACCM adalah Guru Besar di bidang Patologi Veteriner pada Sekolah Kedokteran Hewan dan Biomedis (SKHB) IPB University.  Beliau dikenal sebagai akademisi, peneliti, dan praktisi veteriner dengan kepakaran utama dalam patologi veteriner, patologi tumor, neuropatologi, diagnostik patologi, kultur sel dan jaringan, serta pengembangan herbal medicine veteriner. Beliau menyelesaikan pendidikan dokter hewan dan magister di IPB, kemudian meraih gelar Ph.D. di bidang Pathology and Preventive Veterinary Medicine dari United Graduate School of Veterinary Sciences Yamaguchi University, Jepang. Prof. Bambang adalah salah seorang pemegang Diplomate Asian College of Conservation Medicine dan Brevet Ahli Patologi Veteriner Indonesia. Selain itu, Prof. Bambang juga memiliki pengalaman postdoctoral di bidang neuropatologi, termasuk riset terkait penyakit prion di Georg-August University Göttingen, Jerman. Dalam karier akademiknya, saat ini Prof. Bambang menjabat sebagai Kepala Divisi Patologi Veteriner serta Ketua Program Studi Magister Ilmu Biomedis Hewan di SKHB IPB. Sejak 2016 hingga saat ini sebagai Guest Professor pada University of Miyazaki, Jepang, dan pada 2016–2019 di Faculty of Veterinary Science Royal University of Agriculture, Cambodia.  Minat dan kontribusi ilmiah beliau meliputi patologi penyakit degeneratif, tumor pada hewan, penyakit zoonotik, biosecurity, animal welfare, penggunaan hewan coba dalam penelitian biomedis, serta pengembangan kapasitas pendidikan kedokteran hewan di tingkat nasional dan internasional. Hingga saat ini Prof. Bambang sudah menulis lebih dari 100 makalah ilmiah yang dipublikasikan pada jurnal ilmiah nasional dan internasional serta makalah seminar pada berbagai seminar ilmiah nasional maupun internasional. Beliau sudah meneliti sebanyak 56 judul penelitian dengan 26 judul sebagai Principal Investigator/PI dengan mendapatkan dana hibah dari dalam dan luar negeri seperti Jepang, Jerman, Thailand, Amerika, Korea, Taiwan, Australia, dll, serta memiliki 8 paten. Sebagai pendidik, Prof. Bambang sudah meluluskan lebih dari 392 mahasiswa dari berbagai strata, bidang ilmu dan perguruan tinggi, mulai dari S1, S2, S3, Profesi Dokter Hewan, Spesialis dan Subspesialis. Di tingkat nasional, beliau sangat aktif dalam organisasi profesi kedokteran hewan, menjabat sebagai salah satu ketua pada Pengurus Besar Perhimpunan Dokter Hewan Indonesia (PB PDHI) tahun 2010-2018, menjabat sebagai Ketua Cabang Bogor hingga Ketua Pengurus Pusat Perkumpulan Pemberantasan Penyakit Parasitik Indonesia (P4I) tahun 1996-2008, dan Ketua Umum Asosiasi Patologi Veteriner Indonesia (APVI) tahun 2008-2017. Prof. Bambang juga aktif dalam organisasi profesi veteriner global, sebagai President Asian Society of Veterinary Pathology (ASVP) pada tahun 2009-2011. Pada tahun 2020-2022 beliau adalah orang Indonesia pertama yang duduk sebagai councilor pada World Veterinary Association (WVA) yang berkedudukan di Brussel, Belgia. Saat ini Prof. Bambang menjabat sebagai Ketua IV yang membawahkan kluster Kesehatan pada Forum Organisasi Profesi IPTEKS Indonesia (FOPI). Sejak 2018 hingga saat ini, Prof. Bambang menjabat sebagai Sekretaris Jenderal Federation of Asian Veterinary Associations (FAVA) yang berkedudukan di Bangkok, Thailand dan Fukuoka, Jepang. Dengan pengalaman panjang di dunia akademik, penelitian, dan organisasi profesi, Prof. Bambang berkontribusi aktif dalam penguatan dan pengembangan ilmu kedokteran hewan dan biomedis di Indonesia maupun Asia.

Dr. drh. Rahayu Woro Wiranti, Institut Pertanian Bogor

Dr. drh. Rahayu Woro Wiranti adalah Dosen di Divisi Patologi Veteriner, Sekolah Kedokteran Hewan dan Biomedis (SKHB), IPB University. Beliau dikenal sebagai akademisi dan peneliti dengan kepakaran utama di bidang patologi veteriner, khususnya patologi komparatif dan patologi hewan satwa liar. Beliau menyelesaikan pendidikan dokter hewan di Fakultas Kedokteran Hewan IPB pada tahun 2015 dan di tahun yang sama juga mendapatkan beasiswa Program Magister dan Doktor untuk Sarjana Unggul (PMDSU) Batch 2 dari Kementerian Pendidikan Tinggi, Sains dan Teknologi Republik Indonesia untuk pendidikan Doktoralnya tanpa mengambil Magister. Selama menempuh pendidikan Doktoral, Dr Woro mendapat kesempatan internship di Laboratory of Comparative Pathology, Graduate School of Veterinary Medicine, Hokkaido University Japan. Dr Woro juga mendapatkan Post Doctoral dari IPB pada tahun 2021. Kontribusi ilmiah Dr Woro diawali dengan penelitian potensi penularan penyakit zoonotik (virus dan cendawan) asal kelelawar buah di wilayah Indonesia. Penelitian tersebut menjadi topik skripsi hingga disertasi dan tetap dilanjutkan menjadi riset utama saat ini selain juga melakukan penelitian pada babi hutan, babi domestik, satwa akuatik, dan hewan laboratorium. Dr Woro aktif melakukan penelitian terkait kedokteran hewan dan biomedis serta aktif dalam kegiatan diagnostik patologi dari kasus-kasus lapang terkait patologi veteriner dan sitopatologi. Dr Woro merupakan anggota aktif dari Asosiasi Patologi Veteriner Indonesia (APVI).

Referensi

Abou, D. S., et al. (2015). In vivo imaging of cancer models: a multifaceted approach. Trends in Cancer, 1(1), 52-67. https://doi.org/10.1016/j.trecan.2015.08.005

Acevedo-Arozena, A., et al. (2008). A comprehensive assessment of the ENU-induced mouse mutant repertoire. Science, 321(5887), 394-400.

Aeffner, F., et al. (2019). Introduction to digital image analysis in whole-slide imaging: a white paper from the Digital Pathology Association. Journal of Pathology Informatics, 10, 9. https://doi.org/10.4103/jpi.jpi_82_18

Affara, N. I., et al. (2021). Models of Cutaneous Squamous Cell Carcinoma. Frontiers in Oncology, 11, 702742. https://doi.org/10.3389/fonc.2021.702742

Alizadeh, A. A., et al. (2015). Toward understanding and exploiting tumor heterogeneity. Nature Medicine, 21(8), 846–853. https://doi.org/10.1038/nm.3915

Arriaga-Canon, C., et al. (2020). The role of diet and lifestyle in prostate cancer: insight from DNA methylation and animal models. Nutrients, 12(9), 2697. https://doi.org/10.3390/ nu12092697

Aslantürk, Ö. S. (2018). In Vitro Cytotoxicity and Cell Viability Assays: Principles, Advantages, and Disadvantages. In Genotoxicity and Mutagenicity. IntechOpen. https://doi.org/10.5772/ intechopen.71927

Ballesta, A., Innominato, P. F., Dallmann, R., Rand, D. A., & Lévi, F. A. (2017). Systems Chronotherapeutics. Pharmacological Reviews, 69(2), 161–199. https://doi.org/10.1124/pr.116.013441

Bankhead, P., et al. (2017). QuPath: Open source software for digital pathology image analysis. Scientific Reports, 7(1), 16878. https://doi.org/10.1038/s41598-017-17204-5

Barrow, P. C. (2017). Developmental and reproductive toxicology. In Haschek and Rousseaux's Handbook of Toxicologic Pathology (3rd ed., Vol. 1, pp. 587-633). Academic Press. https://doi.org/10.1016/B978-0-12-801533-1.00021-X

Baumans, V. (2011). Environmental enrichment for laboratory rodents and rabbits: requirements of rodents, rabbits, and research. ILAR Journal, 46(2), 162-170. https://doi.org/10. 1093/ilar.46.2.162

Boopathy, L., Arumugam, S., Ponnusamy, K., Kumar, S., Gopal, T., Durai, S., Ravikumar, S., & Arumugam, M. (2025). Animal Models: A Tool for Colon Cancer Research. Cell Biochemistry and Function, 43. https://doi.org/10.1002/cbf.70087

Bosland, M. C. (2019). Animal models for the study of prostate carcinogenesis. Journal of Cellular Physiology, 234(5), 5529-5540. https://doi.org/10.1002/jcp.27406

Botham, P. A. (2004). Acute toxicity testing in animals. Toxicology in Vitro, 18(2), 225-230. https://doi.org/10.1016/j.tiv.2003.10.001

Cao, L., Liu, X., Lin, E. J., Wang, C., Choi, E. Y., Riban, V., ... & During, M. J. (2010). Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition. Cell, 142(1), 52-64. https://doi.org/10.1016/j. cell.2010.05.029

Carbone, L. (2021). Pain management standards in the eighth edition of the Guide for the Care and Use of Laboratory Animals. Journal of the American Association for Laboratory Animal Science, 51(3), 322-328.

Cardiff, R. D., et al. (2017). The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene, 36(16), 2247-2263. https://doi.org/10.1038/onc.2016.364

Carpenter, A. E., et al. (2006). CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biology, 7(10), R100. https://doi.org/10.1186/gb-2006-7-10-r100

Chapin, R. E., et al. (2004). The role of the alternative animal screening assays in the US National Toxicology Program. Farmaco, 59(9), 701-704. https://doi.org/10.1016/j.farmac. 2004.07.005

Cora, M. C. (2022). The Importance of Rodent Models in Carcinogenicity Testing. Toxicologic Pathology, 50(2), 269–279. https://doi.org/10.1177/01926233211068969

Cross, S. E., et al. (2018). Topical drug delivery in preclinical models of skin cancer. Journal of Controlled Release, 279, 14-25. https://doi.org/10.1016/j.jconrel.2018.04.004

El-Kenawi, A. E., & El-Remessy, A. B. (2013). Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales. British Journal of Pharmacology, 170(4), 712-729. https://doi.org/10.1111/bph.12344

Evans, G. O. (2008). Animal Clinical Chemistry: A Primer for Toxicologists. CRC press.

Filipski, E., King, V. M., Li, X., Granda, T. G., Mormont, M. C., Liu, X., ... & Lévi, F. (2009). Host circadian clock as a control point in tumor progression. Journal of the National Cancer Institute, 95(22), 1731-1736. https://doi.org/10.1093/jnci/djg113

Force, T., et al. (2007). Cardiotoxicity of cancer chemotherapy: a scientific and clinical overview. Circulation, 115(5), e123-e127. https://doi.org/10.1161/CIRCULATIONAHA.106.671343

Fridman, W. H., et al. (2012). The immune contexture in human tumours: impact on clinical outcome. Nature Reviews Cancer, 12(4), 298–306. https://doi.org/10.1038/nrc3245

Gaba, R. C., et al. (2011). Animal models of transarterial chemoembolization for hepatocellular carcinoma. Journal of Vascular and Interventional Radiology, 22(11), 1593-1600. https://doi.org/10.1016/j.jvir.2011.08.016

Ganguly, S. S., Li, X., & Miranti, C. K. (2021). The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and metastasis. Frontiers in Oncology, 11, 718302. https://doi.org/10.3389/fonc. 2021.718302

Gao, X., Sanderson, S. M., Dai, Z., Reid, M. A., Cooper, D. E., Lu, M., ... & Locasale, J. W. (2019). Dietary methionine influences therapy in mouse cancer models and alters human metabolism. Nature, 572(7769), 397-401. https://doi.org/10. 1038/s41586-019-1437-1

Gaskill, B. N., et al. (2020). The impact of the cage environment on the welfare and utility of laboratory mice. Animal Welfare, 29(3), 227-243. https://doi.org/10.7120/09627286.29.3.227

Gnanasekaran, S., et al. (2021). The impact of diet on animal models of cancer. Cancers, 13(11), 2636. https://doi.org/10.3390/ cancers13112636

Graffi, I., et al. (1968). Virus of the hamster papova-lymphoma. Journal of the National Cancer Institute, 40(5), 867-878.

Grankvist, R., et al. (2019). Pharmacokinetic and pharmacodynamic considerations in the use of osmotic pumps in preclinical studies. Journal of Pharmacological and Toxicological Methods, 97, 1-6. https://doi.org/10.1016/j.vascn.2019.03.001

Groeneveld, S., et al. (2021). Best practices for tissue sample handling for molecular analysis in preclinical research. Journal of Pharmacological and Toxicological Methods, 111, 107095. https://doi.org/10.1016/j.vascn.2021.107095

Gu, F. X., et al. (2012). Local and systemic delivery of cancer therapeutics. Advanced Drug Delivery Reviews, 64(12), 1293-1306. https://doi.org/10.1016/j.addr.2012.06.007

Haines, D. C., et al. (2001). Pathology of aging B6;129 mice. Toxicologic Pathology, 29(6), 653-661. https://doi.org/10.1 080/019262301753385988

Hardy, B., et al. (2017). Genetic toxicology: The evolution of the science and the regulatory landscape. Toxicology Research and Application, 1, 2397847317735398. https://doi.org/10.1177/ 2397847317735398

Harvell, D. M., et al. (2019). The N-methyl-N-nitrosourea (MNU) rat model of hormone-responsive breast cancer. Journal of Visualized Experiments, (145), e59155. https://doi.org/ 10.3791/59155

Hayashi, M., et al. (2016). The micronucleus test: a guide to its use in genetic toxicology. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 811, 27-80. https://doi.org/ 10.1016/j.mrgentox.2016.05.006

Haynes, B. F., et al. (2010). Cardio-oncology: Clinical and translational research using the rabbit model of HTLV-1 infection. Journal of Translational Medicine, 8, 1-12.

Hedrick, M. (2017). Routes of administration in preclinical studies. In A Comprehensive Guide to Toxicology in Preclinical Drug Development (pp. 231-252). Academic Press.

Heiman, M. L., & Greenway, F. L. (2016). A healthy formulation for weight loss and maintenance: the role of purified ingredients. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 310(11), R1131-R1137. https://doi.org/ 10.1152/ajpregu.00085.2016

Hiddinga, B. I., et al. (2019). Preclinical evaluation of drug combinations for cancer therapy. Trends in Pharmacological Sciences, 40(12), 929-940. https://doi.org/10.1016/j.tips.2019. 10.002

Holliday, D. L., & Grunda, J. M. (2010). The 4T1 murine mammary carcinoma model. In Tumor Models in Cancer Research (pp. 265-276). Humana Press. https://doi.org/10.1007/978-1-60761-941-3_13

Hor, S. Y., et al. (2022). A review of the preclinical toxicity evaluation of herbal medicines. Frontiers in Pharmacology, 13, 901551. https://doi.org/10.3389/fphar.2022.901551

Hsu, C. Y., et al. (2019). A practical guide for the administration of substances to laboratory animals. Journal of Visualized Experiments, (149), e59223. https://doi.org/10.3791/59223

ICH. (2000). S5(R2) Guideline on detection of toxicity to reproduction for medicinal products & toxicity to male fertility. International Council for Harmonisation.

ICH. (2005). S6(R1) Preclinical safety evaluation of biotechnology-derived pharmaceuticals. International Council for Harmonisation.

ICH. (2011). S2(R1) Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use. International Council for Harmonisation.

Ittmann, M., et al. (2013). Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee. Cancer Research, 73(9), 2718-2736. https://doi.org/10.1158/0008-5472.CAN-12-4213

Jackson, S. J., et al. (2017). The influence of the host on the outcome of chemotherapy in preclinical cancer models. Cancer Research, 77(12), 3128-3135. https://doi.org/10.1158/0008-5472.CAN-16-3343

Jensen, M. M., et al. (2018). The validity and reproducibility of caliper-based tumour volume measurements in preclinical cancer studies. PLoS One, 13(9), e0203561. https://doi.org/10.1371/ journal.pone.0203561

Jiang, W., et al. (2017). Local drug delivery in cancer chemotherapy. Expert Opinion on Drug Delivery, 14(1), 61-75. https://doi.org/10.1080/17425247.2016.1218413

Johnstone, C. N., et al. (2015). E0771, a syngeneic mouse mammary cancer model for assessing cancer metabolism and drug response in vivo. Disease Models & Mechanisms, 8(10), 1339-1347. https://doi.org/10.1242/dmm.020473

Kawabata, T. T., & Germolec, D. R. (2018). Immunotoxicology. In Casarett & Doull’s Toxicology: The Basic Science of Poisons (9th ed.). McGraw-Hill.

Kier, L. D. (2010). Veterinary Necropsy Procedures. CRC Press.

Kim, I. S. (2018). Immune-competent mouse models for triple-negative breast cancer. BMB Reports, 51(3), 118–125. https://doi.org/10.5483/BMBRep.2018.51.3.029

Kling, R. R. (2023). Carcinogen-induced mouse models of breast cancer. Methods in Molecular Biology, 2643, 23-34. https://doi.org/10.1007/978-1-0716-2949-3_2

Kokolus, K. M., et al. (2013). Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature. Proceedings of the National Academy of Sciences, 110(50), 20176-20181. https://doi.org/10.1073/pnas.1304291110

Langford, D. J., Bailey, A. L., Chanda, M. L., Clarke, S. E., Drummond, T. E., Echols, S., ... & Mogil, J. S. (2010). Coding of facial expression of pain in the laboratory mouse. Nature Methods, 7(6), 447-449. https://doi.org/10.1038/nmeth.1455

Le, C. P., Nowell, C. J., Kim-Fuchs, C., & Sloan, E. K. (2016). Chronic stress in mice drives blood vessel formation. Nature Communications, 7(1), 1-12. https://doi.org/10.1038/ ncomms10634

Li, J. J., & Li, S. A. (1984). Estrogen-induced tumorigenesis in the Syrian hamster: roles of metabolism and hormonal effects. Archives of Toxicology. Supplement, 7, 113–127. https://doi.org/10.1007/978-3-642-69919-0_12

Li, Z., Zheng, W., Wang, H., Cheng, Y., Fang, Y., Wu, F., Sun, G., Sun, G., Lv, C., & Hui, B. (2021). Application of Animal Models in Cancer Research: Recent Progress and Future Prospects. Cancer Management and Research, 13, 2455–2475. https://doi.org/10.2147/cmar.s302565

Liu, K., et al. (2024). Animal models of skin cancer: A comprehensive review. Journal of Dermatological Science, 113(2), 65-74. https://doi.org/10.1016/j.jdermsci.2023.12.004

Logan, R. W., et al. (2022). The impact of circadian disruption on the tumour microenvironment. Nature Reviews Cancer, 22(2), 75-90. https://doi.org/10.1038/s41568-021-00424-6

Lope, V., et al. (2022). The role of obesity in the relationship between diet and breast cancer. Nutrients, 14(3), 666. https://doi.org/10.3390/nu14030666

Lukas, G., et al. (2009). Intraperitoneal administration of drugs: a review of the literature. Journal of Applied Toxicology, 29(1), 1-13. https://doi.org/10.1002/jat.1384

Mahmoud, N. S., et al. (2022). Selectivity of anticancer agents. European Journal of Medicinal Chemistry, 239, 114510. https://doi.org/10.1016/j.ejmech.2022.114510

Malone, K. E., et al. (2012). Epidemiology of leukemia. In Schottenfeld and Fraumeni Cancer Epidemiology and Prevention. Oxford University Press.

Mandarano, M., et al. (2022). Omega-3 fatty acids and the immune system in cancer. Seminars in Cancer Biology, 85, 203-219. https://doi.org/10.1016/j.semcancer.2022.04.004

Mann, P. C., et al. (2012). Best practices for the conduct of the nonclinical portion of toxicology studies. Toxicologic Pathology, 40(5), 727–739. https://doi.org/10.1177/ 0192623312443836

Marabelle, A., et al. (2017). Intratumoral immunotherapy: a new frontier in cancer treatment. Annals of Oncology, 28(suppl_12), xii33-xii43. https://doi.org/10.1093/annonc/ mdx643

Medina, D. (2005). The prevention of breast cancer by dietary factors. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 591(1-2), 160-170. https://doi.org/10.1016/j. mrfmmm.2005.03.026

Meurens, F., Summerfield, A., Nauwynck, H., Saif, L., & Gerdts, V. (2012). The pig: a model for human infectious diseases. Trends in microbiology, 20(1), 50–57. https://doi.org/10.1016/j. tim.2011.11.002

Meyerholz, D. K., & Beck, A. P. (2018). Principles and approaches for reproducible scoring of tissue stains in research. Laboratory Investigation, 98(7), 844-855. https://doi.org/10.1038/s41374-018-0057-0

Mina, L. A., et al. (2015). Tumor-infiltrating lymphocytes in triple-negative breast cancer. Breast Cancer, 22(2), 113-119. https://doi.org/10.1007/s12282-014-0557-y

Møller, P. (2018). The comet assay: a versatile tool for assessing DNA damage and repair. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 812, 1-2. https://doi.org/10.1016/j.mrfmmm.2018.06.002

Mori, M., et al. (2019). Intra-articular drug delivery systems for the treatment of osteoarthritis. Advanced Drug Delivery Reviews, 146, 221-240. https://doi.org/10.1016/j.addr.2019.09.001

Morse, H. C., 3rd, et al. (2012). Bethesda proposals for classification of lymphoid neoplasms in mice. Blood, 120(19), 3869-3886.

Mortelmans, K., & Zeiger, E. (2000). The Ames Salmonella/microsome mutagenicity assay. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 455(1-2), 29-60. https://doi.org/10.1016/s0027-5107(00)00064-6

Moser, V. C. (2011). Functional assays for neurotoxicity testing. Toxicologic Pathology, 39(1), 36-45. https://doi.org/10.1177/ 0192623310389333

Müller-Newen, G., et al. (2017). Ethylnitrosourea-induced leukemia in mice: A model for human AML. Blood Cancer Journal, 7, e555.

Nascimento-Gonçalves, E., Mendes, B., Silva-Reis, R., Faustino-Rocha, A., Gama, A., & Oliveira, P. (2021). Animal Models of Colorectal Cancer: From Spontaneous to Genetically Engineered Models and Their Applications. Veterinary Sciences, 8(4), 59. https://doi.org/10.3390/vetsci8040059

National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. (2011). Guide for the Care and Use of Laboratory Animals. 8th edition. National Academies Press (US). https://www.ncbi.nlm.nih. gov/books/NBK54050/

Neto, Í., Rocha, J., Gaspar, M., & Reis, C. (2023). Experimental Murine Models for Colorectal Cancer Research. Cancers, 15(9), 2570. https://doi.org/10.3390/cancers15092570

Nigro, E., et al. (2020). Ultraviolet Radiation and the Skin: An In-Depth Review of the Skh-1 Mouse Model. Cancers, 12(12), 3823. https://doi.org/10.3390/cancers12123823

Nowak-Sliwinska, P., et al. (2023). Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis, 26, 369–428. https://doi.org/10.1007/s10456-022-09855-4

OECD. (2002). Test No. 423: Acute Oral Toxicity - Acute Toxic Class Method. OECD Publishing, Paris. https://doi.org/10.1787/ 9789264070943-en

Pamphile, R., et al. (2022). The importance of in vitro toxicology in drug discovery. Expert Opinion on Drug Discovery, 17(7), 735-746. https://doi.org/10.1080/17460441.2022.2078693

Pantanowitz, L., et al. (2022). Twenty years of digital pathology: An overview of the road travelled, what is on the horizon, and the emergence of cyberpathology. Journal of Pathology Informatics, 13, 100159. https://doi.org/10.1016/j. jpi.2022.100159

Parasuraman, S., et al. (2010). Blood collection in small laboratory animals. Journal of Pharmacology & Pharmacotherapeutics, 1(2), 87–93. https://doi.org/10.4103/0976-500X.72350

Patel, J., et al. (2022). Hamster models of melanoma: History, biology, and current applications. Pigment Cell & Melanoma Research, 35(1), 28-39. https://doi.org/10.1111/pcmr.13010

Paz, C. A., et al. (2012). Intrathecal therapy for leptomeningeal metastases: a review. Journal of Neuro-Oncology, 106(2), 205-213. https://doi.org/10.1007/s11060-011-0661-8

Pellizzon, M. A., & Ricci, M. R. (2020). The common challenges of diet-induced preclinical models of metabolic diseases. Animal Models and Experimental Medicine, 3(3), 205-217. https://doi.org/10.1002/ame2.12122

Plaa, G. L., & Hewitt, W. R. (Eds.). (1989). Toxicology of the liver. Raven Press.

Powell, M. D., et al. (2013). Large animal models for leukemia research. Current Protocols in Pharmacology, 60(1), 1-15.

Prokop, S., et al. (2019). CNS drug delivery: a focus on the blood-brain barrier. Expert Review of Neurotherapeutics, 19(11), 1083-1094. https://doi.org/10.1080/14737175.2019.1656514

Rai, S. N., et al. (2021). Animal models of prostate cancer: from discovery to clinical trials. American Journal of Translational Research, 13(8), 8689-8714.

Ramaiah, S. K. (2011). A toxicologist guide to the diagnostic interpretation of hepatic clinical pathology data in rodents. Toxicologic Pathology, 39(2), 383-394. https://doi.org/10. 1177/0192623310395535

Rauth, S., et al. (2017). Preclinical imaging in cancer research. Expert Opinion on Drug Discovery, 12(4), 385-397. https://doi.org/10.1080/17460441.2017.1294833

Richmond, J. (2020). The 3Rs: A Past, Present, and Future of Animal Experimentation. Animal Technology and Welfare, 19(1), 1-14.

Richmond, J. Y., & McKinney, R. W. (Eds.). (2014). Biosafety in microbiological and biomedical laboratories. US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institutes of Health.

Rieger, A. M., Nelson, K. L., Konowalchuk, J. D., & Barreda, D. R. (2011). Modified annexin V/propidium iodide apoptosis assay for accurate assessment of cell death. Journal of visualized experiments: JoVE, (50), 2597. https://doi.org/10.3791/2597

Routy, B., Le Chatelier, E., Derosa, L., et al. (2018). Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors. Science, 359(6371), 91–97. https://doi.org/ 10.1126/science.aan3706

Ruehl-Fehlert, C., et al. (2003). A harmonized nomenclature for proliferative and non-proliferative lesions of the rat and mouse haematolymphoid system. Toxicologic Pathology, 31(Suppl), 75–90. https://doi.org/10.1080/01926230390174952

Ruggieri, A., Liberto, M. C., & Fiume, G. (2021). The 3Rs in Oncology: An Update on the Role of In Vivo Models. Cancers, 13(16), 4169. https://doi.org/10.3390/cancers13164169

Ruifrok, A. C., & Johnston, D. A. (2001). Quantification of histochemical staining by color deconvolution. Analytical and Quantitative Cytology and Histology, 23(4), 291-299.

Russo, J., & Russo, I. H. (1996). Experimentally induced mammary tumors in rats. Breast Cancer Research and Treatment, 39(1), 7–20. https://doi.org/10.1007/BF01806093

Saban, R., et al. (2014). A murine model of bladder cancer: technical aspects of the procedure. Journal of Visualized Experiments, (87), e51433. https://doi.org/10.3791/51433

Schacht, M. A., et al. (2020). The porcine prostate: a clinically relevant model for the evaluation of focal ablation technologies. Urology, 141, 186.e1-186.e7. https://doi.org/10.1016/j. urology.2020.03.036

Schraverus, H., Larondelle, Y., & Page, M. (2022). Beyond the Lab: What We Can Learn about Cancer from Wild and Domestic Animals. Cancers, 14(24), 6177. https://doi.org/10.3390/cancers14246177

Sellers, R. S., et al. (2022). Use of Animal Models in Translational Research. Veterinary Pathology, 59(1), 8-24. https://doi.org/10.1177/03009858211042738

Sewduth, R., & Georgelou, K. (2024). Relevance of Carcinogen-Induced Preclinical Cancer Models. Journal of Xenobiotics, 14(1), 96–109. https://doi.org/10.3390/jox14010006

Shamseddine, A. A., et al. (2021). N-methyl-N-nitrosourea (MNU)-induced mammary carcinogenesis: a model for ER-positive breast cancer. Cancers, 13(16), 4153. https://doi.org/10.3390/cancers13164153

Sivandzade, F., et al. (2019). The role of mitochondria in neurodegenerative diseases. Journal of cellular physiology, 234(8), 12693-12702. https://doi.org/10.1002/jcp.28185

Slater, N. A., et al. (2021). The two-stage model of skin carcinogenesis: A critical review. Experimental Dermatology, 30(8), 1045-1055. https://doi.org/10.1111/exd.14362

Slaoui, M., & Fiette, L. (2011). Histopathology procedures: from tissue sampling to histopathological evaluation. In Drug Safety Evaluation (pp. 69-82). Humana Press. https://doi.org/10. 1007/978-1-60761-849-2_4

Slaoui, M., et al. (2018). Histopathology of the rat immune system. In Toxicologic Pathology.

Sonabend, A. M., et al. (2020). Local drug delivery for the treatment of glioblastoma. Nature Reviews Clinical Oncology, 17(9), 557-575. https://doi.org/10.1038/s41571-020-0381-0

Southam, D. S., et al. (2016). Intranasal administration of drugs to the lungs of mice. Journal of Visualized Experiments, (111), e54112. https://doi.org/10.3791/54112

Stokes, W. S. (2000). Humane endpoints in animal experimentation for biomedical research and testing. ILAR Journal, 41(2), 59-60. https://doi.org/10.1093/ilar.41.2.59

Stritt, M., et al. (2020). Orbit Image Analysis: An open-source whole slide image analysis tool. PLoS Computational Biology, 16(2), e1007313. https://doi.org/10.1371/journal.pcbi.1007313

Sutton, T. T., et al. (2022). A review of preclinical toxicology study designs for new drug development. Journal of Pharmacological and Toxicological Methods, 116, 107198. https://doi.org/10.1016/j.vascn.2022.107198

Talbert, E. E., & Guttridge, D. C. (2016). The role of IKK in cancer-associated cachexia. Molecular and Cellular Endocrinology, 438, 23-31. https://doi.org/10.1016/j.mce.2016.08.019

Tan, J. L., et al. (2021). Topical and transdermal drug delivery for the treatment of skin cancers. Advanced Drug Delivery Reviews, 173, 219-242. https://doi.org/10.1016/j.addr.2021.03.016

Theodoulidis, V. I., et al. (2021). The abscopal effect in cancer immunotherapy. Clinical Oncology, 33(3), 187-197. https://doi.org/10.1016/j.clon.2020.12.012

Turner, P. V., et al. (2011). Administration of substances to laboratory animals: the why, the how, and the when. Journal of the American Association for Laboratory Animal Science, 50(5), 576-591.

Vaidya, V. S., Waikar, S. S., & Ferguson, M. A. (2008). Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clinical Toxicology, 46(8), 701-714. https://doi.org/10.1080/15563650802243884

Varghese, F., et al. (2014). Immunohistochemistry methods for formalin-fixed paraffin-embedded tissue sections. Methods in Molecular Biology, 1180, 47-74. https://doi.org/10.1007/978-1-4939-1062-5_5

Vesely, M. D., Kershaw, M. H., Schreiber, R. D., & Smyth, M. J. (2011). Natural innate and adaptive immunity to cancer. Annual Review of Immunology, 29, 235–271. https://doi.org/10.1146/ annurev-immunol-031210-101324

Vlachogiannis, G., et al. (2021). Patient-derived xenografts and allografts in cancer research. Trends in Cancer, 7(9), 802-817. https://doi.org/10.1016/j.trecan.2021.03.003

Voelkl, B., et al. (2020). Reproducibility of preclinical animal research improves with standardisation of the study design. Nature Reviews Neuroscience, 21(11), 633-634. https://doi.org/10. 1038/s41583-020-0356-9

Wang, T., Chen, Z., Zhang, Y., Liu, M., Sui, H., & Tang, Q. (2025). Recent advances in the development and application of colorectal cancer mouse models. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1553637

Wang, Y., et al. (2023). Species differences in skin carcinogenesis: A comparative analysis of mouse and rat models. Toxicologic Pathology, 51(4), 189-201. https://doi.org/10.1177/01926233 231178901

Wang, Y., Zhang, L., Feng, W., Liu, W., Xue, X., & Feng, S. (2025). Research advancements and evaluation of multifactor‐induced murine models for gastric cancer. Animal Models and Experimental Medicine, 8, 1923-1934. https://doi.org/10.1002/ ame2.70043

Whittaker, A. L., et al. (2021). The role of refinement in improving animal welfare and scientific outcomes in research. Animals, 11(11), 3045. https://doi.org/10.3390/ani11113045

Wlodkowic, D., et al. (2011). Apoptosis and beyond: assessing cell death with mitochondrial membrane potential probes. Methods, 54(2), 209-214. https://doi.org/10.1016/j.ymeth. 2011.02.002

Wong, G., et al. (2023). The Skh-1 hairless mouse model: A review of its use in photobiology and photocarcinogenesis. Photochemistry and Photobiology, 99(3), 567-580. https://doi.org/10.1111/php.13789

Workman, P., et al. (2010). Guidelines for the welfare and use of animals in cancer research. British Journal of Cancer, 102(11), 1555-1577. https://doi.org/10.1038/sj.bjc.6605642

Xue, Y., Shi, W., Lun, B., Kan, M., Jia, M., Wu, Y., & Yang, L. (2025). Preclinical research models for endometrial cancer: development and selection of animal models. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1512616

Zhang, L., et al. (2025). Mechanisms and applications of N-Methyl-N’-nitro-N-nitrosoguanidine in animal tumor models: current situation and challenges. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1681270

Zhang, X., Xu, Y., Cao, J., Li, T., Wang, J., Tao, J., Zhang, L., & Li, Z. (2025). Mechanisms and applications of N-Methyl-N’-nitro-N-nitrosoguanidine in animal tumor models: current situation and challenges. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1681270

Zhou, J., Liu, C., Amornphimoltham, P., Cheong, S., Gutkind, J., Chen, Q., & Wang, Z. (2024). Mouse Models for Head and Neck Squamous Cell Carcinoma. Journal of Dental Research, 103(6), 585–595. https://doi.org/10.1177/00220345241240997

Zhou, Y., Xia, J., Xu, S., She, T., Zhang, Y., Sun, Y., Wen, M., Jiang, T., Xiong, Y., & Lei, J. (2023). Experimental mouse models for translational human cancer research. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1095388

Zwicker, A., et al. (2023). Porcine skin as a model for human wound healing and scarring. Burns & Trauma, 11, tkad003. https://doi.org/10.1093/burnst/tkad003

Prinsip dan Aplikasi Hewan Model dalam Penelitian Kanker

Unduhan

Preview
GOOGLE PLAYBOOK

Diterbitkan

28 Mei 2026
Hak Cipta (c) 2026 Prof. Dr. Drs. H. Kusmardi, M.Sc., CIRR, Prof. drh. Bambang Pontjo Priosoeryanto, M.S., Ph.D., APVet., DACCM, Dr. drh. Rahayu Woro Wiranti (Author)

Lisensi

Creative Commons License

Artikel ini berlisensiCreative Commons Attribution-ShareAlike 4.0 International License.

Detail format terbitan yang tersedia: Preview

Preview

ISBN-13 (15)

978-634-278-419-8

Dimensi Fisik

Cara Mengutip

Prinsip dan Aplikasi Hewan Model dalam Penelitian Kanker. (2026). PENERBIT KARYA BAKTI MAKMUR (KBM) INDONESIA. https://librarypenerbitkbm.science/index.php/buku/catalog/book/1333